Cancer Monoclonal Antibodies Market Outlook (2024-2031)
Cancer monoclonal antibodies are laboratory-made molecules designed to target and bind to specific proteins on the surface of cancer cells. These antibodies are engineered to recognize and attach to particular antigens associated with cancer cells, which can help the immune system identify and destroy the cancer cells more effectively. Monoclonal antibodies can also be used to deliver toxins or...
0 Comments 0 Shares 527 Views 0 Reviews